Quarterly report [Sections 13 or 15(d)]

Interim Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.26.3
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2024 $ 413,242 $ 19,468 $ 4,189 $ (304,100) $ 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Exercise of stock options $ 405 213     618
Exercise of stock options (in shares) 464,807        
Redemption of RSUs $ 283 (343)     (60)
Redemption of RSUs (in shares) 253,415        
Stock compensation   668     668
Net income (loss)     (28) (10,898) (10,926)
Ending Balance at Mar. 31, 2025 $ 413,930 20,006 4,161 (314,998) 123,099
Ending Balance (in shares) at Mar. 31, 2025 364,819,260        
Beginning Balance at Dec. 31, 2024 $ 413,242 19,468 4,189 (304,100) 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Net income (loss)         (59,172)
Ending Balance at Sep. 30, 2025 $ 430,219 19,539 4,334 (363,417) 90,675
Ending Balance (in shares) at Sep. 30, 2025 375,852,609        
Beginning Balance at Mar. 31, 2025 $ 413,930 20,006 4,161 (314,998) 123,099
Beginning Balance (in shares) at Mar. 31, 2025 364,819,260        
Stock compensation   (123)     (123)
Net income (loss)     73 (20,956) (20,883)
Ending Balance at Jun. 30, 2025 $ 413,930 19,883 4,234 (335,954) 102,093
Ending Balance (in shares) at Jun. 30, 2025 364,819,260        
Shares issued for cash $ 15,168       15,168
Shares issued for cash (in shares) 9,980,095        
Share issue costs $ (379)       (379)
Exercise of warrants $ 501       501
Exercise of warrants (in shares) 257,500        
Exercise of stock options $ 999 (46)     953
Exercise of stock options (in shares) 795,754        
Stock compensation   (298)     (298)
Net income (loss)     100 (27,463) (27,363)
Ending Balance at Sep. 30, 2025 $ 430,219 19,539 4,334 (363,417) 90,675
Ending Balance (in shares) at Sep. 30, 2025 375,852,609        
Beginning Balance at Dec. 31, 2025 $ 432,761 19,645 4,044 (378,998) 77,452
Beginning Balance (in shares) at Dec. 31, 2025 378,169,709        
Exercise of warrants $ 33,031       33,031
Exercise of warrants (in shares) 19,129,999        
Exercise of stock options $ 65       65
Exercise of stock options (in shares) 32,145        
Redemption of RSUs   (35)     (35)
Stock compensation   224     224
Net income (loss)     914 (28,775) (27,861)
Ending Balance at Mar. 31, 2026 $ 465,857 19,834 4,958 (407,773) 82,876
Ending Balance (in shares) at Mar. 31, 2026 397,331,853        
Beginning Balance at Dec. 31, 2025 $ 432,761 19,645 4,044 (378,998) $ 77,452
Beginning Balance (in shares) at Dec. 31, 2025 378,169,709        
Exercise of stock options (in shares)         1,441,473
Net income (loss)         $ (60,984)
Ending Balance at Sep. 30, 2026 $ 468,126 20,717 6,261 (442,199) 52,905
Ending Balance (in shares) at Sep. 30, 2026 398,741,181        
Beginning Balance at Mar. 31, 2026 $ 465,857 19,834 4,958 (407,773) 82,876
Beginning Balance (in shares) at Mar. 31, 2026 397,331,853        
Exercise of stock options $ 836       836
Exercise of stock options (in shares) 442,860        
Stock compensation   487     487
Net income (loss)     1,439 (16,692) (15,253)
Ending Balance at Jun. 30, 2026 $ 466,693 20,321 6,397 (424,465) 68,946
Ending Balance (in shares) at Jun. 30, 2026 397,774,713        
Exercise of stock options $ 1,433 (286)     1,147
Exercise of stock options (in shares) 966,468        
Redemption of RSUs   (10)     (10)
Stock compensation   692     692
Net income (loss)     (136) (17,734) (17,870)
Ending Balance at Sep. 30, 2026 $ 468,126 $ 20,717 $ 6,261 $ (442,199) $ 52,905
Ending Balance (in shares) at Sep. 30, 2026 398,741,181